Publikationen (41) Publikationen von Antonio Parrado Gonzalez

2022

  1. Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies

    Glycobiology, Vol. 32, Núm. 2, pp. 84-100

2021

  1. Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection

    Frontiers in Immunology, Vol. 12

  2. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. PCR Array Technology in Biopsy Samples Identifies Up-Regulated mTOR Pathway Genes as Potential Rejection Biomarkers After Kidney Transplantation

    Frontiers in Medicine, Vol. 8

  4. The roles of Cdc42 and Rac1 in the formation of plasma membrane protrusions in cancer epithelial HeLa cells

    Molecular Biology Reports, Vol. 48, Núm. 5, pp. 4285-4294

  5. Variable distribution of dock‐d proteins between cytosol and nucleoplasm in cell lines, effect of interleukin‐4 on dock10 in b‐cell lymphoid neoplasms, and validation of a new dock10 antiserum for immunofluorescence studies

    Antibodies, Vol. 10, Núm. 3

2020

  1. Expression of DOCK10.1 protein revealed with a specific antiserum: insights into regulation of first exon isoforms of DOCK10

    Molecular Biology Reports, Vol. 47, Núm. 4, pp. 3003-3010

  2. Expression of DOCK9 and DOCK11 Analyzed with Commercial Antibodies: Focus on Regulation of Mutually Exclusive First Exon Isoforms

    ANTIBODIES, Vol. 9, Núm. 3

  3. Identification of differentially expressed genes profiles in a combined mouse model of Parkinsonism and colitis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. The role of DOCK10 in the regulation of the transcriptome and aging

    Heliyon, Vol. 5, Núm. 3

2018

  1. DOCK9 induces membrane ruffles and Rac1 activity in cancer HeLa epithelial cells

    Biochemistry and Biophysics Reports, Vol. 14, pp. 178-181

  2. Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications

    Cytotherapy, Vol. 20, Núm. 9, pp. 1110-1123

  3. The transcriptional response of mouse spleen B cells to IL-4: Comparison to the response of human peripheral blood B cells

    Biochemistry and Biophysics Reports, Vol. 16, pp. 56-61

2016

  1. Dock10 regulates CD23 expression and sustains B-cell lymphopoiesis in secondary lymphoid tissue

    Immunobiology, Vol. 221, Núm. 12, pp. 1343-1350

2015

  1. Dock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cells

    Biology Open, Vol. 4, Núm. 5, pp. 627-635

  2. IL-4 up-regulates miR-21 and the miRNAs hosted in the CLCN5 gene in chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 4

2014

  1. The Gene Expression Response of Chronic Lymphocytic Leukemia Cells to IL-4 Is Specific, Depends on ZAP-70 Status and Is Differentially Affected by an NFkB Inhibitor

    PLoS ONE, Vol. 9, Núm. 10

2011

  1. Cryopreservation impact on blood progenitor cells: Influence of diagnoses, mobilization treatments, and cell concentration

    Transfusion, Vol. 51, Núm. 4, pp. 799-807

  2. Human and mouse DOCK10 splicing isoforms with alternative first coding exon usage are differentially expressed in T and B lymphocytes

    Human Immunology, Vol. 72, Núm. 7, pp. 531-537

2008

  1. Dock10, a novel CZH protein selectively induced by interleukin-4 in human B lymphocytes

    Molecular Immunology, Vol. 45, Núm. 12, pp. 3411-3418